Biofarm S.A.

BIOFARM SA

ROHealthcareBVB: BIOCUI 341563CAEN 2120Bucureşti, Municipiul Bucureşti369 employees (2025 average)IFRS

Investment brief

Investment brief: Biofarm S.A.

Create a free account to read 3 full briefs a month: verdict, strengths, risks, how you could invest and what the price implies. No card needed.

Founding members

The first 100 accounts get 3 months free

98 of 100 free places left · 2 taken

Create your account and get full access for 3 months — no card, no automatic charge. After that it is 20 € a month, only if you choose to continue.

Create a free account

Already have an account? Sign in

Dividends (BVB)

Fiscal yearPer shareEx-dividendRecord datePaymentTotal
20250.140263 RON29 Jun 202630 Jun 202610 Jul 2026RON 138.21m
20250.042 RON13 May 202614 May 202629 May 2026RON 41.39m
20240.031 RON18 Aug 202519 Aug 20255 Sept 2025RON 30.55m
20230.031 RON20 Aug 202421 Aug 20246 Sept 2024RON 30.55m

As published by the Bucharest Stock Exchange, read on 13 Nov 2026. BVB · All BVB dividends →

Key figures · FY2025

Revenue
RON 319.34m
Growth
+11.4%
Net income
RON 100.63m
Net margin
31.5%
Cash
RON 170.25m
Equity
RON 548.35m
Employees (average)
369

Four-year trend

Revenue
2024: RON 286.78mRON 286.78m20242025: RON 319.34mRON 319.34m2025
Net income
2024: RON 74.4mRON 74.4m20242025: RON 100.63mRON 100.63m2025

Annual figures as filed with the Ministry of Finance for the two latest fiscal years; growth computed in code. Source: data.gov.ro, Situații financiare (CC BY 4.0).

Place in every ranking

This company is not in the rankings (they cover companies with at least USD 1 bn in revenue).

Figures for FY2025 (year ending 2025-12-31) from the company's annual financial statements as filed with the Romanian Ministry of Finance (open data on data.gov.ro, CC BY 4.0), in RON. Net turnover (I13), net result (I18 − I19), cash (I5) and equity (I10) as filed; growth and margins computed in code. Operating result and cash flow are not in that data. These lists rank companies by reported figures. A high rank is a fact about the numbers, not a recommendation to buy, sell or hold, and not personalised advice. Past results do not predict future returns.

Find a company